INTRODUCTION {#sec1}
============

Due to high rates of infections due to ESBL producing *Enterobacteriaceae* in India, carbapenems are extensively used for their treatment \[[@cit0001]\]. This lead to the emergence of carbapenem-resistant Enterobacteriaceae (CRE) due to plasmid mediated NDM-1 metallo-betalactamase in 2010 \[[@cit0002]\]. Soon after, NDM-1 producing CRE were reported from all parts of India, including the remote islands of Andaman & Nicobar. Subsequently polymyxins (colistin & polymyxin B) were launched as an effective option to treat CRE. Polymyxins are cationic compounds that bind to the negatively charged phosphate group of the lipopolysaccharide (LPS) causing cell death by disruption and loss of integrity of cell membrane \[[@cit0003]\]. They are active against a wide variety of Gram-negative pathogens but has no activity against Gram-positive and anaerobic pathogens. For the past few years, colistin and polymyxin B have been used mostly in combination with a broad spectrum betalactam to treat infections due to CRE \[[@cit0004]\]. Though colistin was used extensively, the dosing, most often would have been sub-therapeutic due to reasons like lack of clarity on the optimum dose, high cost, absence of loading dose and poor renal function leading to emergence of colistin resistance. Colistin resistance is primarily due decrease in the negative charge of the outer membrane due to addition of positively charged L-Ara-N and PEtN molecules thereby decreasing the affinity between colistin and its target \[[@cit0005]\]. This modification is mediated by the *pmrHFIJKLM* operon which in turn is regulated by the,*phoP/phoQ* two component system \[[@cit0005]\]. A small transmembrane protein *mgrB* negatively regulates the *phoP/phoQ*system preventing activation of *pmrHFIJKLM* operon in *K. pneumoniae*. Previous studies have reported that insertional inactivation of *mgrB* gene in *K.pneumoniae* lead to upregulation of the *phoP/phoQ* system, causing overexpression of the *pmrHFIJKLM* operon, resulting in colistin resistance \[[@cit0006]\]. It was also found that insertion of different types of insertion sequence (IS) at different locations into the *mgrB* gene lead to its inactivation \[[@cit0005],[@cit0006]\]. Mutations in *mgrB, phoP/phoQ, pmrA, pmrB, pmrC,* and *crrABC* regulatory systems have also been found responsible for colistin resistance \[[@cit0007]\]. Plasmid mediated colistin resistance due to *mcr-1* to *mcr-5* encoding for phosphoethanolamine transferase are also being increasingly reported from all over the world \[[@cit0008]\]. Though colistin resistant *K. pneumoniae* have often been reported in India there are only two recent articles characterizing the underlying mechanism \[[@cit0009],[@cit0010]\].

MATERIALS AND METHODS {#sec2}
=====================

The study was conducted from January to June 2017 in a 1,200 bedded tertiary care teaching hospital in South India. Colistin-resistant non-duplicate (one isolate per patient) *K. pneumoniae* isolates encountered during routine susceptibility testing using VITEK 2 (bioMerieux) automated system were included in the study. Out of 932 isolates, 17 were found to be resistant to colistin using breakpoints recommended by EUCAST (\> 2mg/L resistant; and ≤ 2mg/L susceptible) \[[@cit0011]\]. Resistance to colistin in these 17 isolates was confirmed by CLSI recommended broth microdilution method \[[@cit0012]\]. Colistin-susceptible *K. pneumoniae* ATCC 70063 was used as control. They were also tested for *bla* ~CTX-M~ ~(~detects CTX-M-1-, CTX-M-2-, and CTX-M-9-like-encoding genes) and *bla* ~NDM-1~ genes by PCR \[[@cit0002],[@cit0013]\]. To determine the mechanism for colistin resistance PCR amplification and sequencing of the specific for *mgrB* gene was performed using specific primers (*mgr*B-extF:5′-TTAAGAAGGCCGTGCTATCC-3' and *mgr*B-extR:5′-AAGGCGTTCATTCTACCACC-3') \[[@cit0007]\]. Plasmid mediated colistin resistance due *mcr*-*1* and *mcr*-*2* to was investigated by PCR \[[@cit0008]\]. The study was approved by the Institutional Ethics Committee of our institute. (IEC-AIMS 2017-MICROB-117)

RESULTS {#sec3}
=======

PCR amplification of the *mgrB* gene of the 17 *K. pneumoniae* isolates revealed a larger\~1000bp) amplicon in three (CR8, 12, & 28) when compared with the wild type *mgrB* ampiclon (250 bp). Sequencing of these amplicons showed that *mgrB* was disrupted by the insertion of IS*Kpn14*, a IS element belonging to the IS*1* family ([figure 1](#f0001){ref-type="fig"}). In CR8 the insertion occurred between the nucleotides 123 and 124 and was bracketed by 7 bp target site duplication (CACTATT). In the CR28 the insertion occurred between the nucleotides 51 and 92 and was bracketed by 9 bp target site duplication (GGCTGCCTG) while in CR12 insertion was observed between the nucleotides 132 and 133 and was bracketed by 9 bp target site duplication (ATAAATTTA). In all the three cases transposon was inserted in the reverse orientation. Sequencing of the remaining 14 isolates with wild type *mgrB* ampiclon (250 bp) showed mutation only in one isolate (CR6). The CR6 isolate had a frame-shift mutation after the second codon leading to six alternative amino acids followed by a premature stop codon.

![Schematic representation of different insertion events identified in the mgrB gene. (a) isolate CR8, (b) isolates CR 28,(c) isolate CR 12](revespquimioter-31-406-g001){#f0001}

The clinical and demographic details and the susceptibility patterns are given in [table 1](#t0001){ref-type="table"}. All isolates were resistant to colistin (\> 16 mg/L) by Vitek 2 system. MICs for colistin by broth-microdilution ranged from 4-1,024 mg/L. None of the isolates were positive for NDM-1 by PCR ([table 1](#t0001){ref-type="table"}). Isolate CR12 was a non-ESBL susceptible to all antibiotics except for colistin. Isolate CR28 and CR8 were ESBL producer. None of the isolates were positive for plasmid mediated colistin resistance genes *mcr*-*1* and *mcr*-*2* by PCR .

###### 

Demographics, susceptibility, and molecular characteristics of colistin-resistant *K. pneumoniae* isolates.

  Sample ID                                  CR28                                          CR12                        CR8                                                          CR6
  ------------------------------------------ --------------------------------------------- --------------------------- ------------------------------------------------------------ -------------------------------------------------
  Age/Sex                                    58/M                                          44/M                        68/M                                                         49/M
  Underlying condition                       DM,CLD, Child B, Left above knee amputation   Asymptomatic bacterinuria   CLD, Child B, subdural haematoma, 2 months hospitalization   Motor neuron disease, bronchopneumonia, sepsis.
  Outcome                                    Survived                                      Asymptomatic                Expired                                                      Survived
  Sample                                     Tissue                                        Urine                       Urine                                                        Sputum
  Ticarcillin/clavulanic acid                R                                             S                           R                                                            R
  Piperacillin/tazobactam                    R                                             S                           R                                                            R
  Ceftazidime                                R                                             S                           R                                                            R
  Cefoperazone/sulbactam                     R                                             S                           R                                                            R
  Cefepime                                   R                                             S                           R                                                            R
  Aztreonam                                  R                                             S                           R                                                            R
  Doripenem                                  S                                             S                           S                                                            R
  Imipenem                                   S                                             S                           S                                                            R
  Meropenem                                  S                                             S                           S                                                            R
  Amikacin                                   R                                             S                           R                                                            R
  Gentamicin                                 R                                             S                           R                                                            R
  Ciprofloxacin                              R                                             S                           R                                                            R
  Minocycline                                R                                             S                           R                                                            R
  Tigecycline                                I                                             S                           R                                                            I
  Colistin MIC broth microdilution (VITEK)   32 mg/L (16 mg/L)                             16 mg/L (8 mg/L)            1,024 mg/L (16 mg/L)                                         4 mg/L (8 mg/L)
  Cotrimoxazole                              S                                             S                           S                                                            R
  PCR                                                                                                                                                                               
  NDM-1                                      Neg                                           Neg                         Neg                                                          Neg
  CTX-M                                      Pos                                           Neg                         Pos                                                          Neg
  *mcr-1*                                    Neg                                           Neg                         Neg                                                          Neg
  *mcr-2*                                    Neg                                           Neg                         Neg                                                          Neg
  *mgrB* truncated by IS                     Kpn14                                         Kpn14                       Kpn14                                                        Premature stop codon
  Insertion site between                     +51 and +92                                   +132 and +133               +123 and +124                                                NA

S = susceptible; I = intermediate; R= resistant; Neg = negative; Pos = positive

DISCUSSION {#sec4}
==========

Reports on molecular characterization of colistin resistant isolates from India are scarce. Only two publications from India reported ten *K. pneumoniae* isolates with mutations in the *mgrB, phoP/phoQ, pmrA, pmrB, pmrC,* and *crrABC* regulatory systems \[[@cit0010]\]. To our knowledge there have been no previous reports of colistin resistance in *K. pneumoniae* due to insertional inactivation of the *mgr*B from India. Here we report three cases of infection with *K. pneumoniae* resistant to colistin due to insertional inactivation of *mgrB* gene.

Isolate CR8 was surprisingly susceptible to most of the antibiotics and was resistant only to colistin. Further it was isolated from a patient with asymptomatic bacterinuria. Similarly, Kieffer *et al.* had also reported a susceptible *K. pneumoniae* isolate recovered from a case of bovine mastitis with resistance to colistin due to insertional inactivation by IS *903B* element belonging to IS*5* family \[[@cit0014]\]. The most common IS causing truncation of the *mgrB* gene belong to the IS5 family \[[@cit0015]\]. IS*Kpn14* is a 768 bp IS belonging to the IS*1* family. Insertional inactivation by IS*Kpn14* has been previously reported from a solitary isolate from Colombia and France, three isolates from Turkey and two from Italy \[[@cit0007],[@cit0014]-[@cit0016]\]. In all our three isolates the IS*Kpn14* was inserted at different sites.

The study showed that colistin resistance in 23.5% (4/17) *K. pneumoniae* isolates was due to loss of function of *mgrB* which is not in agreement with a recent study from India which reported a rate of 50% \[[@cit0009]\]. We describe for the first-time from India, insertional inactivation of *mgrB* by IS*Kpn14* inserted at different sites, responsible for colistin resistance. Frame shift mutation of *mgrB* resulting in colistin resistance has been described earlier in a solitary study from India \[[@cit0010]\]. The resistance in the remaining 13 isolates may be due to mutations in *phoP/phoQ, pmrA, pmrB, pmrC,* and *crrABC* regulatory systems as reported in a previous study from India. As opposed to previous reports of pan resistant isolates from India, two of our isolates were not carbapenemase producer among them one was also susceptible to most of the antibiotics. Our study was limited by the fact that mutations in *phoP/phoQ, pmrA, pmrB, pmrC,* and *crrABC* regulatory systems which are also responsible for colistin resistance were not investigated and *K. pneumoniae* strain typing was also not done to determine clonality.

The study showed that colistin resistance in 20% of the *K. pneumoniae* isolates was due to loss of function of *mgrB*. We describe for the first-time from India, insertional inactivation of *mgrB* by IS*Kpn14* inserted at different sites, responsible for colistin resistance. Plasmid mediated colistin resistance due to *mcr-1* and *mcr-2* was not identified in *K. pneumoniae* from India.
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